ArticleEndocrine journal2026

Long-term effectiveness and safety of daily growth hormone therapy in Japanese children with Noonan syndrome: a post-marketing surveillance study.

Koji Muroya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.